Human B-type natriuretic peptide – a survey of the patent literature

Bibliography

• De Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981;28:89-94
   PubMed Web of Science ®Google Scholar
• Sudoh T, Kangawa K, Minamino M, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988;332:78-81
   PubMed Web of Science ®Google Scholar
• Hall C. Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail 2004;6:257-60
   PubMed Web of Science ®Google Scholar
• Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans – evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991;87:1402-12
   PubMed Web of Science ®Google Scholar
• Sudoh T, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 1990;168:863-70
   PubMed Web of Science ®Google Scholar
• Takei Y, Takahashi A, Watanabe TX, et al. A novel natriuretic peptide isolated from eel cardiac ventricles. FEBS Lett 1999;1282:317-20
   Google Scholar
• Singh G, Kuc RE, Maguire JJ, et al. Novel snake venom ligand dendroaspis natriuretic peptide is selective for natriuretic peptide receptor-A in human heart: downregulation of natriuretic peptide receptor-A in heart failure. Circ Res 2006;99:183-90
   PubMed Web of Science ®Google Scholar
• Sakamoto M, Nakao K, Kihara M, et al. Existence of atrial natriuretic polypeptide in kidney. Biochem Biophys Res Commun 1985;128:1281-7
   Google Scholar
• Rodeheffer RJ. Measuring plasma B-type natriuretic peptide in heart failure: good to go in 2004? J Am Coll Cardiol 2004;44:740-9
   Google Scholar
• Lee CYW, Burnett JC Jr. Nariuretic peptides and therapeutic applications. Heart Fail Rev 2007;12:131-42
   PubMed Web of Science ®Google Scholar
• Koller KJ, Goeddel DV. Molecular biology of the natriuretic peptides and their receptors. Circulation 1992;86:1081-8
   PubMed Web of Science ®Google Scholar
• Hall C. Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail 2004;6:257-60
   PubMed Web of Science ®Google Scholar
• De Bold AJ, Bruneau BG, Kuroski de Bold ML. Mechanical and neuroendocrine regulation of the endocrine heart. Cardiovasc Res 1996;31:7-18
   PubMed Web of Science ®Google Scholar
• Yandle TG, Richards AM, Gilbert A, et al. Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. J Clin Endocrinol Metab 1993;76:832-8
   PubMed Web of Science ®Google Scholar
• Giuliani I, Rieunier F, Larue C, et al. Assay for measurement of intact B-type natriuretic peptide prohormone in blood. Clin Chem 2006;52:1054-61
   Web of Science ®Google Scholar
• Heublein DM, Huntley BK, Boerrigter G, et al. Immunoreactivity and guanosine 3′,5′-cyclic monophosphate activating actions of various molecular forms of human B-type natriuretic peptide. Hypertension 2007;49:1114
   Google Scholar
• Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure, N Engl J Med 2002;347:161-7
   PubMed Web of Science ®Google Scholar
• Mogelvang R, Goetze JP, Schnohr P, et al. Discriminating between cardiac and pulmonary dysfunction in the general population with dyspnea by plasma Pro-B-type natriuretic peptide. J Am Coll Cardiol 2007;50:1694-701
   PubMed Web of Science ®Google Scholar
• Mueller C. B-type natriuretic peptides and the general practitioner. J Am Coll Cardiol 2007;50:1702-3
   Google Scholar
• deFilippi CR, Seliger SL, Maynard S, Christenson RH. Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality. Clin Chem 2007;53:1511-19
   Web of Science ®Google Scholar
• Wong F, Siu S, Liu P, Blendis LM. Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis? Clin Sci 2001;101:621-8
   PubMed Web of Science ®Google Scholar
• Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004;350:655-63
   PubMed Web of Science ®Google Scholar
• Struthers A, Lang C. The potential to improve primary prevention in the future by using BNP/N-BNP as an indicator of silent ‘pancardiac’ target organ damage: BNP/N-BNP could become for the heart what microalbuminuria is for the kidney. Eur Heart J 2007;28:1678-82
   PubMed Web of Science ®Google Scholar
• McKie PM, Rodeheffer RJ, Cataliotti A, et al. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure. Hypertension 2006;47:874-80
   PubMed Web of Science ®Google Scholar
• Siemens Medical Solutions Diagnostics. Extracting reagent for hydrophobic analyte in whole blood. WO2006102612 (2006)
   Google Scholar
• Shinogi & Co. Ltd. Method for inhibiting decomposition of natriuretic peptides and improved method for assaying natriuretic peptides with the use of the same. WO022235 (1999)
   Google Scholar
• Abbot Lab. Human BNP immunospecific antibodies. WO2007056507 (2007)
   Google Scholar
• Abbot Lab. Human ring specific BNP antibodies. WO2006088700 (2006)
   Google Scholar
• I-Stat Corporation. Multiple hybrid immunoassay. WO2004011947 (2004)
   Google Scholar
• Scios, Inc. Assay and reagents for quantifying hBNP. WO1997032900 (1997)
   Google Scholar
• Shinogi & Co. Ltd. Immunoassay method for BNP. WO1999013331 (1999)
   Google Scholar
• DeBold A. Monoclonal antibodies against N-terminus proBNP US20056960472 (2005)
   Google Scholar
• Roche diagnostics GMBH. Method of identifying N-terminal proBNP. WO2000045176 (2000)
   Google Scholar
• Shinogi & Co. Ltd. Monoclonal antibody recognizing C-terminus of hBNP US6677124 (2004)
   Google Scholar
• McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998;351:9-13
   PubMed Web of Science ®Google Scholar
• Redfield MM, Rodeheffer RJ, Jacobsen SJ, et al. Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study. Circulation 2004;109:3176-81
   PubMed Web of Science ®Google Scholar
• Costello-Boerrigter LC, Boerrigter G, Redfield MM, et al. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol 2006;47:345-53
   PubMed Web of Science ®Google Scholar
• Yeo K-T, Lee H-K, Wong K-C, Foote RS. Can exercise-induced changes in B-type natriuretic peptides be used to detect cardiac ischemia? J Card Fail 2005;11:S59-S64
   Google Scholar
• Baylor College of Medicine. Detecting coronary artery disease with BNP during stress testing. WO2004082639 (2004)
   Google Scholar
• Morrow DA, de Lemos JA, Blazing MA, et al. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease. JAMA 2005;294:2866-71
   PubMed Web of Science ®Google Scholar
• Ndrepepa G, Braun S, Schömig A, Kastrati A. Accuracy of N-terminal pro-brain natriuretic peptide to predict mortality in various subsets of patients with coronary artery disease. Am J Cardiol 2007;100:575-8
   Google Scholar
• Biosite Diagnostics, Inc. Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes. WO2002083913 (2002)
   Google Scholar
• Uusimaa P, Ruskoaho H, Vuolteenaho O, et al. Plasma vasoactive peptides after acute myocardial infarction in relation to left ventricular dysfunction. Int J Cardiol 1999;69:5-14
   Google Scholar
• McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 2002;106:416-22
   PubMed Web of Science ®Google Scholar
• Roche Diagnostics GMBH. Method of detecting proBNP with a monoclonal antibody binding to the amino acid 41-46. WO2004099253 (2004)
   Google Scholar
• Roche diagnostics GMBH. Method of detecting native proBNP with a monoclonal antibody binding to the amino acids 38-44. WO2004099252 (2004)
   Google Scholar
• Scios, Inc. Oxidized human BNP. WO2007041645 (2007)
   Google Scholar
• F Hoffmann La-Roche AG. Devices and methods for diagnosing or predicting early stage cardiac dysfunctions. WO2006120152 (2006)
   Google Scholar
• Compugen USA, INC. Novel brain natriuretic peptide variants and methods of use thereof. WO2005072055 (2005)
   Google Scholar
• Diamond C, Man A, Bremer T. Diagnostic markers of cardiovascular illness and methods of use thereof. US20050181386 (2005)
   Google Scholar
• Conen D, Pfisterer M, Martina B. Substantial intraindividual variability of BNP concentrations in patients with hypertension. J Hum Hypert 2006;20:387-91
   PubMedGoogle Scholar
• F Hoffmann-La Roche AG. The use of BNP-type peptides and ANP-type peptides for assessing the risk of suffering from a cardiovascular complication as a consequence of volume overload. WO2006077265 (2006)
   Google Scholar
• F Hoffmann-La Roche AG. The use of cardiac hormones for diagnosing the risk of suffering from a cardiovascular complication as a consequence of cardiotoxic medication. WO2005124364 (2005)
   Google Scholar
• DeBold A. Predicting and detecting cardiac allograft rejection. US20006117644 (2000)
   Google Scholar
• Roche Diagnostics GMBH. Means and methods for predicting cardiovascular complications in subjects suffering from osteoporosis. WO2007104682 (2007)
   Google Scholar
• F Hoffmann La-Roche AG. Use of NT-proANP and NT-proBNP for diagnosing cardiac diseases. WO2006131529 (2006)
   Google Scholar
• Orion Diagnostica OY. Assay for detecting atrial and brain natriuretic peptide prohormones. WO2005003764 (2005)
   Google Scholar
• University of Leicester. Natriuretic peptide fragments. WO2004034903 (2004)
   Google Scholar
• Osaka University. Method for diagnosis of heart failure. US20070065850 (2007)
   Google Scholar
• Miller WL, Hartman KA, Burritt MF, et al. Serial biomarker measurements in ambulatory patients with chronic heart failure. Circulation 2007;116:249-57
   PubMed Web of Science ®Google Scholar
• Kyoto University. Therapeutic drug for heart disease and virus disease. WO2007023815 (2007)
   Google Scholar
• Scios, Inc. Recombinant techniques for production of human brain natriuretic peptide. US19975674710 (1997)
   Google Scholar
• Scios, Inc. Treatment of congestive heart failure with natriuretic peptide and a diuretic. WO2003081246 (2003)
   Google Scholar
• Scios, Inc. Brain natriuretic peptide. US20060030004 (2006)
   Google Scholar
• Nobex Corporation. BNP conjugates and methods of use. WO2006076471 (2006)
   Google Scholar
• AIC. BNP agonists. WO2006108686 (2006)
   Google Scholar
• The Board of Regents of the University of Texas System. Regulation of brain natriuretic peptide and catecholamines for the treatment of cardiovascular diseases. WO2007033211 (2007)
   Google Scholar
• Michaels AD, Klein A, Madden JA, Chatterjee K. Effects of intravenous nesiritide on human coronary vasomotor regulation and myocardial oxygen uptake. Circulation 2003;107;2697-701
   PubMed Web of Science ®Google Scholar
• Iyengar S, Feldman DS, Trupp R, Abraham WT. Nesiritide for the treatment of congestive heart failure. Expert Opin Pharmacother 2004;5:901-7
   PubMed Web of Science ®Google Scholar
• Colucci WS, Elkayam U, Horton DP, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med 2000;343:246-53
   PubMed Web of Science ®Google Scholar
• Marcus LS, Hart D, Packer M, et al. Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial. Circulation 1996;94:3184-9
   PubMed Web of Science ®Google Scholar
• Koller KJ, Goeddel DV. Molecular biology of the natriuretic peptides and their receptors. Circulation 1992;86:1081-8
   PubMed Web of Science ®Google Scholar
• Grantham JA, Borgeson DD, Burnett JC Jr. BNP: pathophysiological and potential therapeutic roles in acute congestive heart failure. Am J Physiol 1997;272:R1077-R1083
   Google Scholar
• Scios, Inc. California Biotechology, Inc. Recombinant techniques for production of novel natriuretic and vasodilator peptides. US19925114923 (1992)
   Google Scholar
• Sackner-Bernstein JD, Kowalski M, et al. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA 2005;293:1900-5
   PubMed Web of Science ®Google Scholar
• Iglesias JI, Depalma L, Hom D, et al. Predictors of mortality in adult patients with congestive heart failure receiving nesiritide retrospective analysis showing a potential adverse interaction between neseritide and acute renal dysfunction. Nephrol Dial Transplant 2007. Epub 2007 Sep 5
   Google Scholar
• Feldman DS, Sun B. Practical application of human B-type natriuretic peptide as a therapeutic intervention in the perioperative setting. Heart Fail Rev 2004;9:203-8
   Google Scholar
• Chen HH, Sundt DJ, Cook DJ, et al. Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot study. Circulation 2007;116:I-133-I-138
   Google Scholar
• Cataliotti A, Chen HH, James KD, Burnett JC Jr. Oral brain natriuretic peptide: a novel strategy for chronic protein therapy for cardiovascular disease. Trends Cardiovasc Med 2007;17:10-14
   Google Scholar
• Mayo Foundation. Adenovirus vectors encoding brain natriuretic peptide US20060025367 (2006)
   Google Scholar
• Mayo Foundation. Chimeric natriuretic peptides. US2005059600 (2005)
   Google Scholar
• Bruins S, Fokkema MR, Römer JW, et al. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin Chem 2004;50:2052-8
   PubMed Web of Science ®Google Scholar